Workflow
募集资金使用
icon
Search documents
新锐股份: 民生证券关于新锐股份向全资子公司增资以实施募投项目的核查意见
Zheng Quan Zhi Xing· 2025-08-27 12:08
Core Viewpoint - The company is increasing capital to its wholly-owned subsidiary, Wuhan New锐合金工具有限公司, to implement the fundraising project "R&D Center Construction Project" using part of the raised funds and some self-owned funds [1][4][5] Fundraising Basic Information - The company raised a total of RMB 135,152.33 million through its initial public offering, with a net amount of RMB 135,152.33 million after expenses [1] - The funds are stored in a special account for fundraising management, ensuring investor protection [2] Fundraising Investment Project - The total investment for the fundraising project is RMB 73,507.10 million, with RMB 65,188.79 million planned to be invested from the raised funds [2] - The company plans to invest up to RMB 4,000 million in Wuhan New锐合金工具有限公司 for the R&D Center Construction Project [3][4] Impact of Capital Increase - The capital increase is aimed at promoting the implementation of the R&D Center Construction Project, improving the efficiency of fund usage, and aligning with the company's development strategy [4][5] - The increase does not change the purpose of the raised funds or the direction of investment, ensuring no harm to the company or shareholders [4][5] Management of Raised Funds - The actual amount of the capital increase will be stored in a special account opened by Wuhan New锐合金工具有限公司, adhering to relevant regulations for fundraising management [4][5] Review Procedures and Opinions - The board and supervisory committee have approved the capital increase, confirming compliance with relevant laws and regulations [5] - The sponsor institution has no objections to the capital increase, affirming that it aligns with the fundraising usage plan and does not harm the interests of the company and shareholders [5]
有方科技: 有方科技:第四届董事会第九次会议决议公告
Zheng Quan Zhi Xing· 2025-08-27 11:25
Meeting Overview - The fourth meeting of the board of directors of Shenzhen Youfang Technology Co., Ltd. was held on August 27, 2025, with all 8 directors present [2] - The meeting was convened in accordance with the Company Law and relevant regulations [2] Board Resolutions - The board approved the "2025 Semi-Annual Report" and its summary, confirming that the report's preparation and review complied with legal and internal regulations [3] - The board ensured that the information disclosed in the semi-annual report is true, accurate, and complete, with no false records or misleading statements [3] - The board also approved the "2025 Semi-Annual Special Report on the Storage and Use of Raised Funds," confirming its compliance with legal requirements [4] Asset Management - The board approved a proposal for a wholly-owned subsidiary to convert part of its self-use properties into investment properties to enhance asset utilization [5] - Specific properties to be converted include: - 3,598.23 square meters at Building 1, No. 1, Songshan Lake, Dongguan - 2,429.92 square meters at Building 1, No. 11, Park Technology Fourth Road - 2,161.96 square meters at Building 1, No. 1, Youfang Group R&D Headquarters [5]
隆达股份: 第二届监事会第十一次会议决议公告
Zheng Quan Zhi Xing· 2025-08-27 10:29
Core Viewpoint - The supervisory board of Jiangsu Longda Superalloy Co., Ltd. has approved several key proposals during its 11th meeting, including the review of the 2025 semi-annual report and the use of idle funds, indicating a commitment to transparency and compliance with regulations [1][2][3][4][5][6][7][8] Group 1: Meeting Overview - The supervisory board meeting was held in person, with all members present and the procedures compliant with relevant laws and regulations [1] - The meeting's resolutions were deemed legally valid and were passed unanimously with no votes against or abstentions [2] Group 2: Financial Reports and Fund Management - The 2025 semi-annual report was approved, confirming that it accurately reflects the company's financial status and operational results [1][2] - The special report on the storage and use of raised funds was also approved, affirming compliance with regulatory requirements and proper use of funds [2][3] - The board agreed to temporarily use part of the idle raised funds to supplement working capital, enhancing fund efficiency and reducing financial costs [3][4] Group 3: Fund Utilization and Debt Management - The proposal to use part of the over-raised funds for permanent working capital supplementation and bank loan repayment was approved, ensuring no harm to shareholder interests [4][5] - The supervisory board also approved the registration of debt financing tools with a total amount not exceeding RMB 1 billion, aimed at improving liquidity management [5] Group 4: Profit Distribution and Project Adjustments - The profit distribution plan for the first half of 2025 was approved, aligning with legal requirements and considering the company's operational needs [6] - The board agreed to postpone certain fundraising project timelines, which aligns with the company's strategic planning and resource optimization [6][7] Group 5: Related Transactions - The board approved a proposal for signing a lease agreement, confirming that the transaction is fair and does not harm the company's or shareholders' interests [7][8]
永安行: 永安行:第五届董事会第五次会议决议公告
Zheng Quan Zhi Xing· 2025-08-27 10:06
Meeting Overview - The fifth meeting of the fifth board of directors of Yong'an Xing Technology Co., Ltd. was held on August 27, 2025, with all 9 directors present, ensuring compliance with relevant laws and regulations [1][2]. Financial Reports - The board approved the 2025 semi-annual report, which was reviewed by the audit committee and is available on the Shanghai Stock Exchange website [1][2]. - A special report on the use of raised funds for the first half of 2025 was also approved, following the guidelines set by the Shanghai Stock Exchange [2]. Capital Changes - The board approved a proposal to change the registered capital and business scope, which includes an increase in registered capital due to the conversion of bonds into shares, totaling 40,159,391 shares [2][3]. - The business scope will be adjusted to include "manufacturing and sales of new energy power equipment," without changing the main business operations [2]. Cash Management - The board approved the use of up to 400 million yuan of idle raised funds and up to 600 million yuan of self-owned funds for cash management, with a rolling usage period of 12 months [3]. Shareholder Meeting - The board agreed to convene the third temporary shareholders' meeting of 2025, with notifications to be published on the Shanghai Stock Exchange website [3][4].
山东黄金: 山东黄金矿业股份有限公司第七届董事会第二次会议决议公告
Zheng Quan Zhi Xing· 2025-08-27 10:06
Meeting Overview - The second meeting of the seventh board of directors of Shandong Gold Mining Co., Ltd. was held on August 27, 2025, with all 9 directors present, complying with relevant regulations [1][2]. Resolutions Passed - The board approved the 2025 semi-annual report and summary, which will be disclosed on the Shanghai Stock Exchange and Hong Kong Stock Exchange [1]. - The board approved the 2025 semi-annual profit distribution plan, with all 9 votes in favor [1]. - The board approved the special report on the storage and actual use of raised funds for the first half of 2025, with all 9 votes in favor [1]. - A risk assessment report regarding Shandong Gold Group Financial Co., Ltd. was approved, with 7 votes in favor after related directors abstained [1]. - The board approved the adjustment of the upper limit for daily related transactions for 2025, with 7 votes in favor after related directors abstained [1]. - The appointment of joint company secretaries was approved, with all 9 votes in favor [1]. - The board authorized the appointment of a dividend agent for H shares and related actions, with all 9 votes in favor [1].
辰欣药业: 中泰证券股份有限公司关于辰欣药业股份有限公司部分募投项目剩余尾款永久补充流动资金的核查意见
Zheng Quan Zhi Xing· 2025-08-27 09:20
中泰证券股份有限公司 关于辰欣药业股份有限公司 部分募投项目剩余尾款永久补充流动资金的核查意见 中泰证券股份有限公司(以下简称"中泰证券"或"保荐机构")作为辰欣 药业股份有限公司(以下简称"辰欣药业"或"公司")首次公开发行股票并上 市的保荐机构,根据《证券发行上市保荐业务管理办法》《上海证券交易所股票 上市规则(2025 年 4 月修订)》 《上市公司募集资金监管规则》和《上海证券交易 所上市公司自律监管指引第 1 号——规范运作(2025 年 5 月修订)》等有关规定 等法律法规的要求,履行了持续督导义务,对辰欣药业本次拟将部分募投项目剩 余尾款永久补充流动资金事项进行了核查,核查情况及核查意见如下: 一、本次公开发行股票募集资金的基本情况 (一)募集资金的基本情况 经中国证券监督管理委员会证监许可[2017]1660 号文核准,公司向社会公开 发行人民币普通股(A 股)股票 10,000 万股,每股面值 1.00 元人民币,发行价 格 11.66 元/股。本次发行募集资金总额为人民币 1,166,000,000.00 元,扣除保荐 及承销费等相关发行费人民币 55,653,163.21 元,实际募集资 ...
天域生物: 前次募集资金使用情况的专项报告
Zheng Quan Zhi Xing· 2025-08-26 16:40
Group 1 - The company raised a total of RMB 402.27 million through a private placement of 48.35 million shares at a price of RMB 8.32 per share, with a net amount of RMB 393.87 million after deducting issuance costs [1][3] - As of June 30, 2025, the balance of the raised funds in the special account was RMB 187,615.74, with an additional RMB 61.69 million remaining unutilized, accounting for 15.33% of the total raised funds [2][3] - The company plans to use the remaining funds according to the construction progress of the Tianchang Longgang Red Culture Tourism Scenic Area project, which is expected to be completed by 2025 [2][3] Group 2 - The company has approved the temporary use of idle raised funds for working capital, with amounts of RMB 130 million, RMB 220 million, and RMB 160 million used in different periods, all of which have been returned to the special account [1][2] - The internal rate of return for the Tianchang Longgang Red Culture Tourism Scenic Area project has been adjusted from 25% to 17% due to project delays, impacting the expected cumulative gross profit [2][3] - The company has confirmed that the actual use of raised funds aligns with the disclosures made in annual reports and other information disclosure documents, with no discrepancies found [2][3]
祥鑫科技: 国金证券股份有限公司关于祥鑫科技股份有限公司使用募集资金向全资子公司增资以实施募集资金投资项目的核查意见
Zheng Quan Zhi Xing· 2025-08-26 16:35
Summary of Key Points Core Viewpoint The report outlines the use of raised funds by Xiangxin Technology Co., Ltd. to increase capital in its wholly-owned subsidiaries for the implementation of investment projects, confirming compliance with relevant regulations and the necessity for project advancement [1][10]. Group 1: Fundraising Overview - In 2020, the company issued convertible bonds totaling RMB 647,005,400, with a net amount raised of RMB 636,315,867.43 after expenses [1]. - In 2022, the company issued 26 million A-shares at RMB 33.69 per share, raising a total of RMB 875,940,000, with a net amount of RMB 863,087,203.80 after related costs [2]. Group 2: Investment Project Details - The 2020 bond issuance was allocated to a project for high-quality precision automotive molds and components, with a planned investment of RMB 64,700.54 million [3]. - The 2022 A-share issuance funds were adjusted for various projects, including the construction of production bases for energy storage and photovoltaic inverters [3]. Group 3: Capital Increase to Subsidiaries - The company plans to invest RMB 67,179,600 in Ningbo Xiangxin Precision Metal Structure Parts Co., Ltd., increasing its registered capital from RMB 150 million to RMB 180 million [4]. - An investment of RMB 50 million is planned for Guangzhou Xiangxin, raising its registered capital from RMB 230 million to RMB 250 million [4]. - Another RMB 50 million will be allocated to Yibin Xiangxin, increasing its registered capital from RMB 80 million to RMB 100 million [4]. Group 4: Subsidiary Information - Ningbo Xiangxin was established in May 2018, with a registered capital of RMB 150 million, focusing on automotive parts and metal products [5]. - Guangzhou Xiangxin, established in July 2017, has a registered capital of RMB 230 million, specializing in automotive engine manufacturing and related services [7]. - Yibin Xiangxin, founded in September 2021, is involved in battery manufacturing and automotive parts development [9]. Group 5: Approval and Compliance - The independent directors and board of supervisors have reviewed and approved the capital increase, confirming compliance with legal and regulatory requirements [10][11]. - The sponsor institution has verified that the capital increase aligns with the company's operational needs and does not harm shareholder interests [12].
天臣医疗: 天臣医疗关于2025年半年度募集资金存放与实际使用情况的专项报告
Zheng Quan Zhi Xing· 2025-08-26 16:35
| 证券代码:688013 证券简称:天臣医疗 公告编号:2025-048 | | | | | --- | --- | --- | --- | | 天臣国际医疗科技股份有限公司 | | | | | 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 | | | | | 述或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 | | | | | 根据中国证券监督管理委员会《上市公司募集资金监管规则》和《上海证券 | | | | | 交易所科创板上市公司自律监管指引第 1 号——规范运作》及相关格式指引等有 | | | | | 关规定,天臣国际医疗科技股份有限公司(以下简称"天臣医疗"、"公司"或"本 | | | | | 公司")董事会编制了 2025 年半年度募集资金存放与实际使用情况专项报告。 | | | | | 一、募集资金基本情况 | | | | | (一)实际募集资金金额及到账时间 | | | | | 天臣医疗经中国证券监督管理委员会《关于同意天臣国际医疗科技股份有限 | | | | | 公司首次公开发行股票注册的批复》(证监许可[2020]2020 号)核准,公司向社 | ...
石大胜华: 申万宏源证券承销保荐有限责任公司关于石大胜华新材料集团股份有限公司使用募集资金向子公司提供借款以实施募投项目的核查意见
Zheng Quan Zhi Xing· 2025-08-26 11:21
Summary of Key Points Core Viewpoint The company, Shida Shenghua New Materials Group Co., Ltd., is utilizing raised funds to provide loans to its subsidiaries for the implementation of investment projects, which has been approved by the board and supervisory committee, ensuring compliance with relevant regulations and protecting shareholder interests [1][8][9]. Fundraising Overview - The company received approval from the China Securities Regulatory Commission for a stock issuance, with a total fundraising amount not exceeding RMB 1,990 million [1]. - The actual net amount raised was RMB 982,169,508.71 after deducting issuance costs [1][2]. Investment Project Funding - The adjusted total amount for investment projects is RMB 982,169,508.71 [2]. - The company plans to allocate RMB 70 million to its wholly-owned subsidiary, Shenghua New Energy Technology (Dongying) Co., Ltd., for a project with an annual production capacity of 11,000 tons of additives [6][8]. - RMB 130 million will be provided to the controlling subsidiary, Dongying Shida Shenghua New Energy Co., Ltd., for a project with an annual production capacity of 100,000 tons of liquid lithium salt [6][8]. - RMB 482,169,508.71 will be allocated to Shenghua New Energy Technology (Wuhan) Co., Ltd. for a project with an annual production capacity of 220,000 tons of lithium battery materials [6][8]. Loan Management and Compliance - The loans will be issued based on project needs, with interest rates reflecting the company's average financing costs [7]. - A tripartite supervision agreement has been signed to ensure proper management of the raised funds [7]. - The company will adhere to regulations regarding the use of raised funds, ensuring no alteration of intended use that could harm shareholder interests [7][9]. Approval Process - The board of directors and the supervisory committee have both approved the use of raised funds for loans to subsidiaries, confirming compliance with regulatory requirements [8][9]. - The sponsor has verified that the process followed necessary procedures and does not harm shareholder interests [9].